Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade. (Q48335626)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Pilar Mur

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Teresa Ribalta

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Barbara Melendez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Manuela Mollejo

2

1 reference

ORCID Public Data File 2021

author name string

Teresa Hernández-Iglesias

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ángel Rodríguez de Lope

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Juan F García

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Concepción Fiaño

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Juan A Rey

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuropathology & Experimental Neurology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

241-249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25668564%20AND%20SRC:MED&resulttype=core&format=json

The 2007 WHO classification of tumours of the central nervous system

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Novel genomic alterations and mechanisms associated with tumor progression in oligodendroglioma and mixed oligoastrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Mutations in CIC and FUBP1 contribute to human oligodendroglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

IDH mutation impairs histone demethylation and results in a block to cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Codeletion of 1p and 19q determines distinct gene methylation and expression profiles in IDH-mutated oligodendroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

The chromatin remodeller ATRX: a repeat offender in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Altered telomeres in tumors with ATRX and DAXX mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Expanding the spectrum of IDH1 mutations in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167

The somatic genomic landscape of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FNEN.0000000000000167